Alger Russell Innovation ETF (INVN)
NYSEARCA: INVN · Real-Time Price · USD
27.19
+0.21 (0.79%)
Nov 13, 2026, 4:00 PM EST - Market closed
| Assets | $10.79M |
| Expense Ratio | 0.55% |
| PE Ratio | 18.14 |
| Forward PE | 14.74 |
| Shares Out | 400,000 |
| Dividend | $0.06 (0.23%) |
| Ex-Dividend Date | Dec 18, 2025 |
| Payout Frequency | n/a |
| Payout Ratio | 4.14% |
| Volume | n/a |
| Open | n/a |
| Previous Close | 26.98 |
| Day's Range | n/a |
| 52-Week Low | 17.75 |
| 52-Week High | 27.77 |
| Beta | n/a |
| Holdings | 51 |
| Inception Date | Jan 6, 2025 |
About INVN
Fund Home PageThe Alger Russell Innovation ETF (INVN) is an exchange-traded fund that is based on the Alger Russell Innovation index. The fund tracks an equal-weighted index of 50 US stocks selected from the Russell 1000 through a fundamental approach. The fund seeks to identify companies at the forefront of innovation. INVN was launched on Jan 6, 2025 and is issued by Alger.
Asset Class Equity
Category Mid-Cap Blend
Region North America
Stock Exchange NYSE Arca
Ticker Symbol INVN
ETF Provider Alger
Index Tracked Alger Russell Innovation Index
Top 10 Holdings
23.68% of assets| Name | Symbol | Weight |
|---|---|---|
| Procore Technologies, Inc. | PCOR | 2.61% |
| Roblox Corporation | RBLX | 2.51% |
| Unity Software Inc. | U | 2.47% |
| DocuSign, Inc. | DOCU | 2.46% |
| Exelixis, Inc. | EXEL | 2.40% |
| Maplebear Inc. | CART | 2.28% |
| Biogen Inc. | BIIB | 2.26% |
| Regeneron Pharmaceuticals, Inc. | REGN | 2.25% |
| BILL Holdings, Inc. | BILL | 2.23% |
| Klaviyo, Inc. | KVYO | 2.22% |
Performance
INVN had a total return of 27.01% in the past year, including dividends. Since the fund's inception, the average annual return has been 18.30%.
